Dermatological Manifestations and Sebum Composition in Parkinson’s Disease
Introduction Parkinson disease (PD) is a multifaceted neurodegenerative disorder known for its hallmark motor symptoms. However, nonmotor manifestations, specifically dermatological changes, precede motor symptoms and may thus serve as vital early indicators of PD. Objectives This article ex...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2025-01-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | https://dpcj.org/index.php/dpc/article/view/4921 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832540727002791936 |
---|---|
author | Meshi Paz Peter Lio |
author_facet | Meshi Paz Peter Lio |
author_sort | Meshi Paz |
collection | DOAJ |
description |
Introduction
Parkinson disease (PD) is a multifaceted neurodegenerative disorder known for its hallmark motor symptoms. However, nonmotor manifestations, specifically dermatological changes, precede motor symptoms and may thus serve as vital early indicators of PD.
Objectives
This article explores the skin-related changes associated with PD, focusing on alterations in sebum composition, microbial dysbiosis, and the potential for leveraging dermatological assessments as early, noninvasive diagnostic markers for PD.
Methods
A comprehensive literature review was conducted to investigate dermatological manifestations of PD, focusing on sebum changes in affected individuals. Research explored the clinical relevance of altered lipid profiles, volatile organic compound (VOC) contributions, and microbiome dysbiosis in those with PD.
Results
Individuals with PD exhibit excess sebum production characterized by altered lipid profiles, including elevated short-chain fatty acids (SCFAs) and disruptions in sphingolipid metabolism. The lipid-rich environment also promotes overgrowth of Malessezia yeast, contributing to varied dermatological symptoms in those with PD. VOCs identified in sebum have been linked to unique odors and serve as biomarkers for diagnostic potential. These findings support the potential for early PD diagnosis through dermatologic assessment and sebum analysis.
Conclusion
Dermatological manifestations in PD offer promising noninvasive biomarkers for early diagnosis. Future research should aim to further elucidate the mechanisms underlying sebum dysregulation in PD and validate the clinical relevance of these biomarkers in larger populations.
|
format | Article |
id | doaj-art-9f1266fc711f472d85c401fbe0ef710e |
institution | Kabale University |
issn | 2160-9381 |
language | English |
publishDate | 2025-01-01 |
publisher | Mattioli1885 |
record_format | Article |
series | Dermatology Practical & Conceptual |
spelling | doaj-art-9f1266fc711f472d85c401fbe0ef710e2025-02-04T15:41:28ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4921Dermatological Manifestations and Sebum Composition in Parkinson’s DiseaseMeshi Paz0Peter Lio1https://orcid.org/0000-0001-7600-0152Tulane University School of MedicineFeinberg School of Medicine, Northwestern University; Medical Dermatology Associates of Chicago Introduction Parkinson disease (PD) is a multifaceted neurodegenerative disorder known for its hallmark motor symptoms. However, nonmotor manifestations, specifically dermatological changes, precede motor symptoms and may thus serve as vital early indicators of PD. Objectives This article explores the skin-related changes associated with PD, focusing on alterations in sebum composition, microbial dysbiosis, and the potential for leveraging dermatological assessments as early, noninvasive diagnostic markers for PD. Methods A comprehensive literature review was conducted to investigate dermatological manifestations of PD, focusing on sebum changes in affected individuals. Research explored the clinical relevance of altered lipid profiles, volatile organic compound (VOC) contributions, and microbiome dysbiosis in those with PD. Results Individuals with PD exhibit excess sebum production characterized by altered lipid profiles, including elevated short-chain fatty acids (SCFAs) and disruptions in sphingolipid metabolism. The lipid-rich environment also promotes overgrowth of Malessezia yeast, contributing to varied dermatological symptoms in those with PD. VOCs identified in sebum have been linked to unique odors and serve as biomarkers for diagnostic potential. These findings support the potential for early PD diagnosis through dermatologic assessment and sebum analysis. Conclusion Dermatological manifestations in PD offer promising noninvasive biomarkers for early diagnosis. Future research should aim to further elucidate the mechanisms underlying sebum dysregulation in PD and validate the clinical relevance of these biomarkers in larger populations. https://dpcj.org/index.php/dpc/article/view/4921Parkinson's Diseasedermatological mnsebum compositionvolatile organic compoundsMalassezia |
spellingShingle | Meshi Paz Peter Lio Dermatological Manifestations and Sebum Composition in Parkinson’s Disease Dermatology Practical & Conceptual Parkinson's Disease dermatological mn sebum composition volatile organic compounds Malassezia |
title | Dermatological Manifestations and Sebum Composition in Parkinson’s Disease |
title_full | Dermatological Manifestations and Sebum Composition in Parkinson’s Disease |
title_fullStr | Dermatological Manifestations and Sebum Composition in Parkinson’s Disease |
title_full_unstemmed | Dermatological Manifestations and Sebum Composition in Parkinson’s Disease |
title_short | Dermatological Manifestations and Sebum Composition in Parkinson’s Disease |
title_sort | dermatological manifestations and sebum composition in parkinson s disease |
topic | Parkinson's Disease dermatological mn sebum composition volatile organic compounds Malassezia |
url | https://dpcj.org/index.php/dpc/article/view/4921 |
work_keys_str_mv | AT meshipaz dermatologicalmanifestationsandsebumcompositioninparkinsonsdisease AT peterlio dermatologicalmanifestationsandsebumcompositioninparkinsonsdisease |